ArticlePharmacoEconomics2022

Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".

Nikolaos Giannelos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.